Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Alnylam Pharmaceuticals (DE:DUL)
FRANKFURT:DUL
Holding DE:DUL?
Track your performance easily
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 500.92M | $ 659.83M | $ 494.33M | $ 439.72M | $ 750.53M |
| Gross Profit | $ 418.94M | $ 592.55M | $ 439.72M | $ 340.42M | $ 671.06M |
| EBIT | $ -108.66M | $ -11.17M | $ -16.97M | $ -106.35M | $ 150.74M |
| EBITDA | $ -95.61M | $ -1.48M | $ -5.00M | $ -82.38M | $ 160.94M |
| Net Income Common Stockholders | $ -111.57M | $ -16.89M | $ -65.94M | $ -137.87M | $ 147.75M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 2.78B | $ 2.62B | $ 2.37B | $ 2.44B | $ 2.41B |
| Total Assets | $ 4.21B | $ 4.01B | $ 3.82B | $ 3.83B | $ 3.84B |
| Total Debt | $ 1.30B | $ 1.30B | $ 1.30B | $ 1.31B | $ 1.31B |
| Net Debt | $ -1.48B | $ -1.32B | $ -1.07B | $ -1.13B | $ -1.10B |
| Total Liabilities | $ 4.17B | $ 4.01B | $ 4.04B | $ 4.05B | $ 4.00B |
| Stockholders Equity | $ 32.35M | $ -3.07M | $ -219.27M | $ -220.64M | $ -165.87M |
| Cash Flow | - | ||||
| Free Cash Flow | $ 39.52M | $ 116.14M | $ -94.49M | $ -45.10M | $ 342.32M |
| Operating Cash Flow | $ 43.71M | $ 124.16M | $ -81.52M | $ -29.80M | $ 359.41M |
| Investing Cash Flow | $ -30.25M | $ 33.94M | $ -67.62M | $ -240.66M | $ -10.76M |
| Financing Cash Flow | $ 102.75M | $ 131.50M | $ 28.91M | $ 39.23M | $ 33.14M |